6533b825fe1ef96bd128332b

RESEARCH PRODUCT

Comparison between sodium dodecylsulphate and cetyltrimethylammonium bromide as mobile phases in the micellar liquid chromatography determination of non-steroidal anti-inflammatory drugs in pharmaceuticals.

M.j. Medina-hernándezSalvador SagradoC. Martı́nez-algabaLaura Escuder-gilabertRosa María Villanueva-camañas

subject

KetoprofenNaproxenSodiumClinical BiochemistryAcemetacinPharmaceutical Sciencechemistry.chemical_elementAnalytical Chemistrychemistry.chemical_compoundBromideDrug DiscoverymedicineSpectroscopyChromatography Micellar Electrokinetic CapillaryDetection limitChromatographyElutionCetrimoniumAnti-Inflammatory Agents Non-SteroidalSodium Dodecyl SulfateReference StandardsSolutionschemistryMicellar liquid chromatographyCalibrationCetrimonium CompoundsIndicators and ReagentsSpectrophotometry Ultravioletmedicine.drug

description

The retention behaviour of non-steroidal anti-inflammatory drugs (NSAIDs) using micellar mobile phases of sodium dodecylsulphate (SDS) is studied and compared with that observed with micellar mobile phases of cetyltrimethylammonium bromide (CTAB). A liquid chromatographic procedure for the determination of acemetacin, diclofenac, indomethacin, ketoprofen, naproxen and tolmetin in pharmaceutical preparations is described. The proposed system uses a Kromasil C18 analytical column and a solution of 0.15 M SDS at pH 3 with 10% 1-propanol as mobile phase. Under these conditions, the studied NSAIDs elute between 6 and 10 min at a 1 mL min(-1) flow rate. Limits of detection (LOD) are lower than 0.5 microg mL(-1). Recoveries in the analysis of the pharmaceutical preparations are ranged between 91 and 104% respect to the nominal content declared by the manufacturers and the relative standard deviations are in general lower than 4%.

10.1016/j.jpba.2004.06.011https://pubmed.ncbi.nlm.nih.gov/15496335